Intermountain Healthcare Establishes Reimbursement Coverage Policy for Pathway Diagnostics’ Tissue of Origin Test

Published: May 17, 2011

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced today that its Pathwork® Tissue of Origin Test is now covered by SelectHealth, the health insurance arm of Intermountain Healthcare. The Tissue of Origin Test helps identify the primary tumor in difficult to diagnose cancer cases, such as those that are metastatic or with a complex clinical history.

Back to news